SPEAKUP ABOUT DRUGS

EIN: 823425247 501(c)(3) Mental Health

BENTONVILLE, AR

Total Revenue
$77,657
Total Expenses
$115,322
Total Assets
$34,168
Net Assets
$-24,974
🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Sign In — Free (10 views/day)

Financial Trends

Organization Details

Formation Year
2017
Legal Domicile
AR
Principal Officer
GINA ALLGAIER
Tax Period
2023-01-01 to 2023-12-31

SPEAKUP ABOUT DRUGS, founded in 2017, is a micro nonprofit in the Mental Health sector that reported $78K in total revenue in fiscal year 2023. Revenue fell 52% from the prior year — a significant decline worth monitoring. Expenses of $115K exceeded revenue, resulting in a 49% operating deficit.

Mission

TO EDUCATE SUPPORT AND ADVOCATE FOR INDIVIDUALS AND FAMILIES WHO ARE VICTIMS OF THE DRUG EPIDEMIC

Program Service Accomplishments

Program 1
Expenses: $115,322

TO EDUCATE SUPPORT AND ADVOCATE FOR INDIVIDUALS AND FAMILIES WHO ARE VICTIMS OF THE DRUG EPIDEMIC

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Sign In — Free (10 views/day)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $77,657
Program Service Revenue $0
Investment Income $0
Other Revenue $0
TOTAL REVENUE $77,657

Expense Breakdown

Grants Paid $0
Salaries & Benefits $47,100
Fundraising Expenses $0
Program Expenses $115,322
Other Expenses $68,222
TOTAL EXPENSES $115,322

Year-over-Year Comparison

2023 2022 Change
Revenue $77,657 $161,593 -0.5%
Expenses $115,322 $166,413 -0.3%
Net Income $-37,665 $-4,820 +6.8%
Key Indicators
✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required
🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Sign In

Governance

Voting Members
5
Independent Members
3
Employees
1
Volunteers
N/A

Governance Policies

✗ Conflict of Interest Policy
✗ Whistleblower Policy
✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School
✗ Operated a Hospital
✗ Provided First Class Travel
⚠ Reported Conflict of Interest
✗ Reported Asset Diversion
✗ Excess Benefit Transaction
✗ Made Political Expenditures
✗ Engaged in Lobbying
✗ Operated Donor Advised Fund
✗ Maintained Art Collections
✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers
5
$43,542
Total Directors
5
$43,542
Key Employees
1
$43,542
Highest Compensated
1
reported
Name Title Hours/Week Role Reportable Comp Other Comp Total
GINA ALLGAIER EXECUTIVE DIRECTOR 0.00
Officer Director Key Emp Highest
$43,542 $0 $43,542
KATY RESTUM DIRECTOR 0.00
Officer Director
$0 $0 $0
ANDREW AGAR DIRECTOR 0.00
Officer Director
$0 $0 $0
PAT ALLGAIER TREASURER 0.00
Officer Director
$0 $0 $0
TERESA BELEW DIRECTOR 0.00
Officer Director
$0 $0 $0
Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year Revenue Expenses Assets Net Income
2024 No data No data No data No data
2023 $77,657 $115,322 $34,168 $-37,665
2022 $161,593 $166,413 $55,906 $-4,820
2021 $287,684 $261,582 $63,657 $26,102
Explore More Nonprofits
→Top 100 Nonprofits in Arkansas →Largest U.S. Nonprofits →Best Rated Nonprofits →Most Efficient Nonprofits

Compare SPEAKUP ABOUT DRUGS with other nonprofits in Arkansas and across the country.

We Value Your Privacy
We use cookies and similar technologies to analyze site traffic and improve your experience. By clicking "Accept All", you consent to our use of cookies for analytics and measurement.